相关实验视频
Updated: Jul 24, 2025

10:32
Development of a Virtual Reality Assessment of Everyday Living Skills
Published on: April 23, 2014
18.5K
针对精神分裂症的积极症状的新型药物治疗
Enrico Capuzzi1, Alice Caldiroli1, Cecilia Quitadamo2
1Fondazione IRCCS, Department of Mental Health and Addiction, San Gerardo Dei Tintori, Monza, Italy.
Expert opinion on pharmacotherapy
|July 4, 2023
概括
新的研究探索了针对精神分裂症积极症状的新型药物治疗方法,包括拉莫特里金和针对免疫和代谢系统的药物. 需要进一步的研究来证实这些发现,并开发有效的治疗方法.
科学领域:
- 精神病学是一个精神病学.
- 药理学 药理学是指药理学的学科.
- 神经科学是一个神经科学.
背景情况:
- 精神分裂症的积极症状与预后不佳有关.
- 很大一部分患者对当前的抗精神病治疗反应有限.
研究的目的:
- 提供针对精神分裂症积极症状的新型药物治疗方法的最新概述.
- 为了确定超越传统抗精神病药物的新兴药理策略.
主要方法:
- 在主要数据库 (PubMed,PsychINFO等) 中进行了全面的文献搜索. 在2023年1月31日之前.
- 审查了关于精神分裂症积极症状的新药学策略的原始文章.
主要成果:
- 有前途的化合物包括lamotrigine,前认知药物 (如donepezil,piracetam) 和在中枢神经系统 (CNS) 外作用的药物,如抗炎和心血管药物.
- 诸如赛莱科克西布,甲铁酸盐,L-氨酸和米尔塔萨这样的化合物显示出潜在的潜力,这表明免疫力和新陈代谢中的新生物标.
- 米尔塔扎可以帮助消极症状,而不会加剧积极症状.
结论:
- 针对不同生物系统的新兴药物疗法为治疗精神分裂症的积极症状提供了新的途径.
- 非中枢神经系统作用药物的有效性突显了免疫和代谢途径对未来药物开发的潜力.
- 进一步的研究和复制研究对于验证这些发现和制定最终的治疗指南至关重要.
更多相关视频
相关概念视频
Drug Therapy
74
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
74
Psychosis: Goals of Pharmacotherapy
170
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
170
Psychosis and Antipsychotic Drugs: Overview
336
The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic...
336
Positive Symptoms Schizophrenia: Hallucinations and Delusions
107
Schizophrenia is a complex psychiatric disorder characterized by a range of symptoms that significantly impact cognition, behavior, and emotional regulation. Among these, the positive symptoms stand out as they involve the addition or exaggeration of normal mental functions, deviating markedly from typical behavior and perception. Hallucinations and delusions are prominent positive symptoms, each profoundly affecting the individual's experience of reality.
Hallucinations
Hallucinations in...
Hallucinations
Hallucinations in...
107
Antipsychotic Drugs: Typical and Atypical Agents
259
Antipsychotic drugs are classified into first-generation (typical) drugs including phenothiazines; and second-generation (atypical) drugs. Chlorpromazine hydrochloride (Thorazine), a phenothiazine derivative, broadly impacts the central, autonomic, and endocrine systems. This drug, along with typical agents like haloperidol (Haldol), primarily works by antagonizing D2 receptors, thus reducing dopaminergic neurotransmission. However, typical antipsychotics can cause side effects such as sedation...
259
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
756
Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
756

